APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Automatic Insulin Dose Adjustment Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Automatic Insulin Dose Adjustment Software Market Analysis and Forecast 2026-2032

Report ID 17407302026 March 2026190 pages

Choose your research edition.

Industry ResearchAutomatic Insulin Dose Adjustment Software Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Automatic Insulin Dose Adjustment Software Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Automatic Insulin Dose Adjustment Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Automatic Insulin Dose Adjustment Software Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Automatic Insulin Dose Adjustment Software Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Automatic Insulin Dose Adjustment Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Automatic Insulin Dose Adjustment Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Automatic Insulin Dose Adjustment Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Automatic Insulin Dose Adjustment Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Automatic Insulin Dose Adjustment Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Automatic Insulin Dose Adjustment Software include Glytec, Beta Bionics, Hygieia, Tandem Diabetics, CamDiab, Medtronic, Novo Nordisk, Omnipod and Tempo Platform, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Automatic Insulin Dose Adjustment Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Automatic Insulin Dose Adjustment Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Automatic Insulin Dose Adjustment Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Automatic Insulin Dose Adjustment Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Automatic Insulin Dose Adjustment Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Automatic Insulin Dose Adjustment Software revenue, projected growth trends, production technology, application and end-user industry.

Automatic Insulin Dose Adjustment Software Segment by Company

Glytec

Beta Bionics

Hygieia

Tandem Diabetics

CamDiab

Medtronic

Novo Nordisk

Omnipod

Tempo Platform

Automatic Insulin Dose Adjustment Software Segment by Type

Open-Loop Systems

Closed-Loop Systems

Automatic Insulin Dose Adjustment Software Segment by Application

Subscription Used

One-time Purchase Used

Automatic Insulin Dose Adjustment Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automatic Insulin Dose Adjustment Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Automatic Insulin Dose Adjustment Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automatic Insulin Dose Adjustment Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Automatic Insulin Dose Adjustment Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Automatic Insulin Dose Adjustment Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Automatic Insulin Dose Adjustment Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Automatic Insulin Dose Adjustment Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Open-Loop Systems Major Player Table 3. Closed-Loop Systems Major Player Table 4. Global Automatic Insulin Dose Adjustment Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Subscription Used Major Player Table 6. One-time Purchase Used Major Player Table 7. Automatic Insulin Dose Adjustment Software Industry Trends Table 8. Automatic Insulin Dose Adjustment Software Industry Drivers Table 9. Automatic Insulin Dose Adjustment Software Industry Opportunities and Challenges Table 10. Automatic Insulin Dose Adjustment Software Industry Restraints Table 11. Global Automatic Insulin Dose Adjustment Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Automatic Insulin Dose Adjustment Software Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Automatic Insulin Dose Adjustment Software Market Share by Region (2021-2026) Table 14. Global Automatic Insulin Dose Adjustment Software Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Automatic Insulin Dose Adjustment Software Market Share by Region (2027-2032) Table 16. Global Automatic Insulin Dose Adjustment Software Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Automatic Insulin Dose Adjustment Software Revenue Market Share by Players (2021-2026) Table 18. Global Automatic Insulin Dose Adjustment Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Automatic Insulin Dose Adjustment Software Key Players Headquarters & Area Served Table 20. Global Automatic Insulin Dose Adjustment Software Players, Product Type & Application Table 21. Global Automatic Insulin Dose Adjustment Software Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Automatic Insulin Dose Adjustment Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Automatic Insulin Dose Adjustment Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Automatic Insulin Dose Adjustment Software Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Automatic Insulin Dose Adjustment Software Revenue Market Share by Type (2021-2026) Table 28. Global Automatic Insulin Dose Adjustment Software Revenue Market Share by Type (2027-2032) Table 29. Global Automatic Insulin Dose Adjustment Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Automatic Insulin Dose Adjustment Software Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Automatic Insulin Dose Adjustment Software Revenue Market Share by Application (2021-2026) Table 33. Global Automatic Insulin Dose Adjustment Software Revenue Market Share by Application (2027-2032) Table 34. Glytec Company Information Table 35. Glytec Business Overview Table 36. Glytec Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Glytec Automatic Insulin Dose Adjustment Software Product Portfolio Table 38. Glytec Recent Development Table 39. Beta Bionics Company Information Table 40. Beta Bionics Business Overview Table 41. Beta Bionics Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Beta Bionics Automatic Insulin Dose Adjustment Software Product Portfolio Table 43. Beta Bionics Recent Development Table 44. Hygieia Company Information Table 45. Hygieia Business Overview Table 46. Hygieia Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Hygieia Automatic Insulin Dose Adjustment Software Product Portfolio Table 48. Hygieia Recent Development Table 49. Tandem Diabetics Company Information Table 50. Tandem Diabetics Business Overview Table 51. Tandem Diabetics Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Tandem Diabetics Automatic Insulin Dose Adjustment Software Product Portfolio Table 53. Tandem Diabetics Recent Development Table 54. CamDiab Company Information Table 55. CamDiab Business Overview Table 56. CamDiab Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. CamDiab Automatic Insulin Dose Adjustment Software Product Portfolio Table 58. CamDiab Recent Development Table 59. Medtronic Company Information Table 60. Medtronic Business Overview Table 61. Medtronic Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Medtronic Automatic Insulin Dose Adjustment Software Product Portfolio Table 63. Medtronic Recent Development Table 64. Novo Nordisk Company Information Table 65. Novo Nordisk Business Overview Table 66. Novo Nordisk Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Novo Nordisk Automatic Insulin Dose Adjustment Software Product Portfolio Table 68. Novo Nordisk Recent Development Table 69. Omnipod Company Information Table 70. Omnipod Business Overview Table 71. Omnipod Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Omnipod Automatic Insulin Dose Adjustment Software Product Portfolio Table 73. Omnipod Recent Development Table 74. Tempo Platform Company Information Table 75. Tempo Platform Business Overview Table 76. Tempo Platform Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Tempo Platform Automatic Insulin Dose Adjustment Software Product Portfolio Table 78. Tempo Platform Recent Development Table 79. North America Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2026) & (US$ Million) Table 80. North America Automatic Insulin Dose Adjustment Software Revenue by Type (2027-2032) & (US$ Million) Table 81. North America Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2026) & (US$ Million) Table 82. North America Automatic Insulin Dose Adjustment Software Revenue by Application (2027-2032) & (US$ Million) Table 83. North America Automatic Insulin Dose Adjustment Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. North America Automatic Insulin Dose Adjustment Software Revenue by Country (2021-2026) & (US$ Million) Table 85. North America Automatic Insulin Dose Adjustment Software Revenue by Country (US$ Million) & (2027-2032) Table 86. Europe Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2026) & (US$ Million) Table 87. Europe Automatic Insulin Dose Adjustment Software Revenue by Type (2027-2032) & (US$ Million) Table 88. Europe Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2026) & (US$ Million) Table 89. Europe Automatic Insulin Dose Adjustment Software Revenue by Application (2027-2032) & (US$ Million) Table 90. Europe Automatic Insulin Dose Adjustment Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. Europe Automatic Insulin Dose Adjustment Software Revenue by Country (2021-2026) & (US$ Million) Table 92. Europe Automatic Insulin Dose Adjustment Software Revenue by Country (US$ Million) & (2027-2032) Table 93. China Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2026) & (US$ Million) Table 94. China Automatic Insulin Dose Adjustment Software Revenue by Type (2027-2032) & (US$ Million) Table 95. China Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2026) & (US$ Million) Table 96. China Automatic Insulin Dose Adjustment Software Revenue by Application (2027-2032) & (US$ Million) Table 97. Asia Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2026) & (US$ Million) Table 98. Asia Automatic Insulin Dose Adjustment Software Revenue by Type (2027-2032) & (US$ Million) Table 99. Asia Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2026) & (US$ Million) Table 100. Asia Automatic Insulin Dose Adjustment Software Revenue by Application (2027-2032) & (US$ Million) Table 101. Asia Automatic Insulin Dose Adjustment Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Asia Automatic Insulin Dose Adjustment Software Revenue by Region (US$ Million) & (2021-2026) Table 103. Asia Automatic Insulin Dose Adjustment Software Revenue by Region (US$ Million) & (2027-2032) Table 104. SAMEA Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2026) & (US$ Million) Table 105. SAMEA Automatic Insulin Dose Adjustment Software Revenue by Type (2027-2032) & (US$ Million) Table 106. SAMEA Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2026) & (US$ Million) Table 107. SAMEA Automatic Insulin Dose Adjustment Software Revenue by Application (2027-2032) & (US$ Million) Table 108. SAMEA Automatic Insulin Dose Adjustment Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. SAMEA Automatic Insulin Dose Adjustment Software Revenue by Country (2021-2026) & (US$ Million) Table 110. SAMEA Automatic Insulin Dose Adjustment Software Revenue by Country (US$ Million) & (2027-2032) Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Automatic Insulin Dose Adjustment Software Image Figure 2. Global Automatic Insulin Dose Adjustment Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Automatic Insulin Dose Adjustment Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Open-Loop Systems Image Figure 5. Closed-Loop Systems Image Figure 6. Global Automatic Insulin Dose Adjustment Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Automatic Insulin Dose Adjustment Software Market Size Share 2021 VS 2025 VS 2032 Figure 8. Subscription Used Image Figure 9. One-time Purchase Used Image Figure 10. Global Automatic Insulin Dose Adjustment Software Market Size (US$ Million) & (2021-2032) Figure 11. Global Automatic Insulin Dose Adjustment Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Automatic Insulin Dose Adjustment Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Automatic Insulin Dose Adjustment Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Automatic Insulin Dose Adjustment Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Automatic Insulin Dose Adjustment Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Automatic Insulin Dose Adjustment Software Revenue Market Share by Type (2021-2032) Figure 18. Global Automatic Insulin Dose Adjustment Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Automatic Insulin Dose Adjustment Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Automatic Insulin Dose Adjustment Software Revenue Market Share by Application (2021-2032) Figure 21. North America Automatic Insulin Dose Adjustment Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Automatic Insulin Dose Adjustment Software Revenue Share by Type (2021-2032) Figure 23. North America Automatic Insulin Dose Adjustment Software Revenue Share by Application (2021-2032) Figure 24. North America Automatic Insulin Dose Adjustment Software Revenue Share by Country (2021-2032) Figure 25. United States Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Automatic Insulin Dose Adjustment Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Automatic Insulin Dose Adjustment Software Revenue Share by Type (2021-2032) Figure 30. Europe Automatic Insulin Dose Adjustment Software Revenue Share by Application (2021-2032) Figure 31. Europe Automatic Insulin Dose Adjustment Software Revenue Share by Country (2021-2032) Figure 32. Germany Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Automatic Insulin Dose Adjustment Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Automatic Insulin Dose Adjustment Software Revenue Share by Type (2021-2032) Figure 42. China Automatic Insulin Dose Adjustment Software Revenue Share by Application (2021-2032) Figure 43. Asia Automatic Insulin Dose Adjustment Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Automatic Insulin Dose Adjustment Software Revenue Share by Type (2021-2032) Figure 45. Asia Automatic Insulin Dose Adjustment Software Revenue Share by Application (2021-2032) Figure 46. Asia Automatic Insulin Dose Adjustment Software Revenue Share by Region (2021-2032) Figure 47. Japan Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Automatic Insulin Dose Adjustment Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Automatic Insulin Dose Adjustment Software Revenue Share by Type (2021-2032) Figure 55. SAMEA Automatic Insulin Dose Adjustment Software Revenue Share by Application (2021-2032) Figure 56. SAMEA Automatic Insulin Dose Adjustment Software Revenue Share by Country (2021-2032) Figure 57. Brazil Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Automatic Insulin Dose Adjustment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Open-Loop Systems
  • Closed-Loop Systems
Applications
  • Subscription Used
  • One-time Purchase Used
Companies covered
  • Glytec
  • Beta Bionics
  • Hygieia
  • Tandem Diabetics
  • CamDiab
  • Medtronic
  • Novo Nordisk
  • Omnipod
  • Tempo Platform

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Automatic Insulin Dose Adjustment Software Market by Type
  3. 1.2.1 Global Automatic Insulin Dose Adjustment Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Open-Loop Systems
  5. 1.2.3 Closed-Loop Systems
  6. 1.3 Automatic Insulin Dose Adjustment Software Market by Application
  7. 1.3.1 Global Automatic Insulin Dose Adjustment Software Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Subscription Used
  9. 1.3.3 One-time Purchase Used
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Automatic Insulin Dose Adjustment Software Market Dynamics
  1. 2.1 Automatic Insulin Dose Adjustment Software Industry Trends
  2. 2.2 Automatic Insulin Dose Adjustment Software Industry Drivers
  3. 2.3 Automatic Insulin Dose Adjustment Software Industry Opportunities and Challenges
  4. 2.4 Automatic Insulin Dose Adjustment Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Automatic Insulin Dose Adjustment Software Market Perspective (2021-2032)
  2. 3.2 Global Automatic Insulin Dose Adjustment Software Growth Trends by Region
  3. 3.2.1 Global Automatic Insulin Dose Adjustment Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Automatic Insulin Dose Adjustment Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Automatic Insulin Dose Adjustment Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Automatic Insulin Dose Adjustment Software Revenue by Players
  2. 4.1.1 Global Automatic Insulin Dose Adjustment Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Automatic Insulin Dose Adjustment Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Automatic Insulin Dose Adjustment Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Automatic Insulin Dose Adjustment Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Automatic Insulin Dose Adjustment Software Key Players Headquarters & Area Served
  7. 4.4 Global Automatic Insulin Dose Adjustment Software Players, Product Type & Application
  8. 4.5 Global Automatic Insulin Dose Adjustment Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Automatic Insulin Dose Adjustment Software Market CR5 and HHI
  11. 4.6.3 2025 Automatic Insulin Dose Adjustment Software Tier 1, Tier 2, and Tier 3
5 Automatic Insulin Dose Adjustment Software Market Size by Type
  1. 5.1 Global Automatic Insulin Dose Adjustment Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2032)
  3. 5.3 Global Automatic Insulin Dose Adjustment Software Revenue Market Share by Type (2021-2032)
6 Automatic Insulin Dose Adjustment Software Market Size by Application
  1. 6.1 Global Automatic Insulin Dose Adjustment Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2032)
  3. 6.3 Global Automatic Insulin Dose Adjustment Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Glytec
  2. 7.1.1 Glytec Company Information
  3. 7.1.2 Glytec Business Overview
  4. 7.1.3 Glytec Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Glytec Automatic Insulin Dose Adjustment Software Product Portfolio
  6. 7.1.5 Glytec Recent Developments
  7. 7.2 Beta Bionics
  8. 7.2.1 Beta Bionics Company Information
  9. 7.2.2 Beta Bionics Business Overview
  10. 7.2.3 Beta Bionics Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Beta Bionics Automatic Insulin Dose Adjustment Software Product Portfolio
  12. 7.2.5 Beta Bionics Recent Developments
  13. 7.3 Hygieia
  14. 7.3.1 Hygieia Company Information
  15. 7.3.2 Hygieia Business Overview
  16. 7.3.3 Hygieia Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Hygieia Automatic Insulin Dose Adjustment Software Product Portfolio
  18. 7.3.5 Hygieia Recent Developments
  19. 7.4 Tandem Diabetics
  20. 7.4.1 Tandem Diabetics Company Information
  21. 7.4.2 Tandem Diabetics Business Overview
  22. 7.4.3 Tandem Diabetics Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Tandem Diabetics Automatic Insulin Dose Adjustment Software Product Portfolio
  24. 7.4.5 Tandem Diabetics Recent Developments
  25. 7.5 CamDiab
  26. 7.5.1 CamDiab Company Information
  27. 7.5.2 CamDiab Business Overview
  28. 7.5.3 CamDiab Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 CamDiab Automatic Insulin Dose Adjustment Software Product Portfolio
  30. 7.5.5 CamDiab Recent Developments
  31. 7.6 Medtronic
  32. 7.6.1 Medtronic Company Information
  33. 7.6.2 Medtronic Business Overview
  34. 7.6.3 Medtronic Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Medtronic Automatic Insulin Dose Adjustment Software Product Portfolio
  36. 7.6.5 Medtronic Recent Developments
  37. 7.7 Novo Nordisk
  38. 7.7.1 Novo Nordisk Company Information
  39. 7.7.2 Novo Nordisk Business Overview
  40. 7.7.3 Novo Nordisk Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Novo Nordisk Automatic Insulin Dose Adjustment Software Product Portfolio
  42. 7.7.5 Novo Nordisk Recent Developments
  43. 7.8 Omnipod
  44. 7.8.1 Omnipod Company Information
  45. 7.8.2 Omnipod Business Overview
  46. 7.8.3 Omnipod Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Omnipod Automatic Insulin Dose Adjustment Software Product Portfolio
  48. 7.8.5 Omnipod Recent Developments
  49. 7.9 Tempo Platform
  50. 7.9.1 Tempo Platform Company Information
  51. 7.9.2 Tempo Platform Business Overview
  52. 7.9.3 Tempo Platform Automatic Insulin Dose Adjustment Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Tempo Platform Automatic Insulin Dose Adjustment Software Product Portfolio
  54. 7.9.5 Tempo Platform Recent Developments
8 North America
  1. 8.1 North America Automatic Insulin Dose Adjustment Software Revenue (2021-2032)
  2. 8.2 North America Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Automatic Insulin Dose Adjustment Software Revenue by Type (2027-2032)
  5. 8.3 North America Automatic Insulin Dose Adjustment Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Automatic Insulin Dose Adjustment Software Revenue by Application (2027-2032)
  9. 8.5 North America Automatic Insulin Dose Adjustment Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Automatic Insulin Dose Adjustment Software Revenue by Country
  11. 8.6.1 North America Automatic Insulin Dose Adjustment Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Automatic Insulin Dose Adjustment Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Automatic Insulin Dose Adjustment Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Automatic Insulin Dose Adjustment Software Revenue (2021-2032)
  2. 9.2 Europe Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Automatic Insulin Dose Adjustment Software Revenue by Type (2027-2032)
  5. 9.3 Europe Automatic Insulin Dose Adjustment Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Automatic Insulin Dose Adjustment Software Revenue by Application (2027-2032)
  9. 9.5 Europe Automatic Insulin Dose Adjustment Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Automatic Insulin Dose Adjustment Software Revenue by Country
  11. 9.6.1 Europe Automatic Insulin Dose Adjustment Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Automatic Insulin Dose Adjustment Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Automatic Insulin Dose Adjustment Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Automatic Insulin Dose Adjustment Software Revenue (2021-2032)
  2. 10.2 China Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2032)
  3. 10.2.1 China Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2026)
  4. 10.2.2 China Automatic Insulin Dose Adjustment Software Revenue by Type (2027-2032)
  5. 10.3 China Automatic Insulin Dose Adjustment Software Revenue Share by Type (2021-2032)
  6. 10.4 China Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2032)
  7. 10.4.1 China Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2026)
  8. 10.4.2 China Automatic Insulin Dose Adjustment Software Revenue by Application (2027-2032)
  9. 10.5 China Automatic Insulin Dose Adjustment Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Automatic Insulin Dose Adjustment Software Revenue (2021-2032)
  2. 11.2 Asia Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Automatic Insulin Dose Adjustment Software Revenue by Type (2027-2032)
  5. 11.3 Asia Automatic Insulin Dose Adjustment Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Automatic Insulin Dose Adjustment Software Revenue by Application (2027-2032)
  9. 11.5 Asia Automatic Insulin Dose Adjustment Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Automatic Insulin Dose Adjustment Software Revenue by Country
  11. 11.6.1 Asia Automatic Insulin Dose Adjustment Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Automatic Insulin Dose Adjustment Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Automatic Insulin Dose Adjustment Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Automatic Insulin Dose Adjustment Software Revenue (2021-2032)
  2. 12.2 SAMEA Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Automatic Insulin Dose Adjustment Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Automatic Insulin Dose Adjustment Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Automatic Insulin Dose Adjustment Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Automatic Insulin Dose Adjustment Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Automatic Insulin Dose Adjustment Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Automatic Insulin Dose Adjustment Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Automatic Insulin Dose Adjustment Software Revenue by Country
  11. 12.6.1 SAMEA Automatic Insulin Dose Adjustment Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Automatic Insulin Dose Adjustment Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Automatic Insulin Dose Adjustment Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst